Aumgene Biosciences Private Limited, a active private limited company, was established on 26 May 2004 in Surat, Gujarat, India. Engaging in industrial enzymes & biochemicals within the manufacturing sector, it holds CIN: U24231GJ2004PTC044192. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.39 M.
It upholds a compliant status. Employing 56 professional, Its leadership includes Anand Kumar Daga (Director), Jaikumar Bajaj (Director). Past directors included Shrikumar Daga. It holds ₹26.30 Cr open charges and ₹2.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 8201/5 & 6, Road No. 8, G I D C Sachin,, Surat, Gujarat, 394230.
U24231GJ2004PTC044192
044192
26 May 2004
₹2.50 M
₹2.39 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Aumgene Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Kumar Daga | Director | 26 May 2004 | Current |
| Jaikumar Bajaj | Director | 26 May 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aumgene Biosciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.16% increase. The company also saw a substantial improvement in profitability, with a 55.04% increase in profit. The company's net worth Soared by an impressive increase of 22.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aumgene Biosciences had a promoter holding of 23.44% and a public holding of 76.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹263,000,000.00
₹25,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Dec 2024 | Sidbi | ₹5.90 Cr | Open |
| 09 Nov 2023 | Axis Bank Limited | ₹9.95 Cr | Open |
| 20 Oct 2023 | Axis Bank Limited | ₹9.95 Cr | Open |
| 19 Mar 2014 | Biotechnology Industry Research Assistance Council | ₹5.00 M | Open |
| 14 Dec 2007 | Others | ₹1.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Aumgene Biosciences has a workforce of 56 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aumgene Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aumgene Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Sidbi amounted to Rs. 59.00 M with Charge ID 101013622 was registered on 04 Dec 2024. was documented.
Progress on A charge with Sidbi of Rs. 59.00 M registered on 04 Dec 2024 with Charge ID 101013622 was modified on 04 Dec 2024. was documented.
Progress on Aumgene Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Aumgene Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 99.50 M with Charge ID 100809209 was registered on 09 Nov 2023. was completed.
A charge with Axis Bank Limited amounted to Rs. 99.50 M with Charge ID 100808753 was registered on 20 Oct 2023. was recorded as a recent event.
The CIN of Aumgene Biosciences Private Limited is U24231GJ2004PTC044192.
Aumgene Biosciences Private Limited is headquartered at Plot No. 8201/5 & 6, Road No. 8, G I D C Sachin,, Surat, Gujarat, 394230.
Aumgene Biosciences Private Limited was incorporated on 26 May 2004.
The current directors of Aumgene Biosciences Private Limited are
The primary industry of Aumgene Biosciences Private Limited is Manufacturing.
Aumgene Biosciences Private Limited is unlisted.
The authorized capital of Aumgene Biosciences Private Limited is ₹2.50 M, and the paid-up capital is ₹2.39 M.
The compliance status of Aumgene Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX